Targeted Therapies and their Impact on Melanoma

Steven O’Day, MD
Video Categories: Targeted Therapies

Dr. Steve O’Day works with melanoma and has seen great breakthroughs in targeted therapies and their impact on the disease.

October 16, 2015

The Role of Anti-PD-1 Antibodies

Dr. Sanjiv Agarwala addresses the possibility of updating indications for Nivolumab and Pembrolizumab in the therapeutic arena.

December 3, 2013

Management of Patients with Basal Cell Carcinoma not Eligible for Surgery or Radiation

In this second clinical commentary entitled, Management of Patients with Basal Cell Carcinoma not Eligible for Surgery or Radiation, Joel Claveau, MD, CSPQ, FRCPC; Dirk Schadendorf, MD; Nicole Basset-Seguin, MD, PhD and Aleksandar Sekulic, MD, PhD discuss the need for new treatment options in the care of basal cell carcinoma [ Read More ]